CINC shares popped 60% today. A quick overview:

(CINC) is trading 60% higher at $37.61 today. Shares of the promising biotech company continued to soar today as the stock moved on news that it's treatment for hypertension had reached the middle stage of it's trial.

CinCor Pharma has been trading between a 52-week high of $43.12 and a 52-week low of $13. The stock has a market cap of $1.42 Billion.

CinCor Pharma's mission is to advance promising clinical candidates toward marketing approval and improve the lives of patients suffering from cardio-renal diseases.